Description
Seeking men and women hospitalized with COVID-19 for a study of an investigational drug combination.
Overview
We are studying whether an investigational drug combination is safe and effective for patients hospitalized with COVID-19. The investigational drug combination has previously been studied for use in a different infectious disease called Ebola. Participants will either get an injection of the investigational drug or saltwater (placebo).
What we're hoping for
We hope to evaluate whether the investigational drug combination is safe and effective for people hospitalized with COVID-19.
Additional Information
ClinicalTrials.gov Identifier: NCT04492475